Yarrow Bioscience, Inc.
YARW· Nasdaq
Released Aug 6, 2020, before the open
10-Q filed Aug 6, 2020, 37 days after period end · 0001566044-20-000011
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $11.69M | $0.00 | $10.14M | $449.00K |
| Net Income | -$167.44M | -$18.99M | -$8.35M | -$6.15M |
| EPS Diluted |
Yarrow Bioscience, Inc. · CIK 1566044 · Engraved from SEC EDGAR
| -$4.83 |
| $2.36 |
| -$0.36 |
| -$1.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.